{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T04:05:38Z","timestamp":1746158738375,"version":"3.40.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.arteri.2024.04.002","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T12:58:40Z","timestamp":1715259520000},"page":"100721","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Levels of sCD163 in women rheumatoid arthritis: Relationship with cardiovascular risk markers"],"prefix":"10.1016","volume":"37","author":[{"given":"Oscar","family":"Zaragoza-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Brice\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Rafael","family":"Villafan-Bernal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilse Adriana","family":"Guti\u00e9rrez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9ctor Ugo","family":"Rojas-Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo Adolfo","family":"Alonso-Silverio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Alarc\u00f3n-Paredes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Eduardo","family":"Navarro-Zarza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Morales-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rub\u00e9n","family":"Rodr\u00edguez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris Paola","family":"Guzm\u00e1n-Guzm\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arteri.2024.04.002_bib0255","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/35051594","article-title":"Identification of the haemoglobin scavenger receptor","volume":"409","author":"Kristiansen","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.arteri.2024.04.002_bib0260","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/jlb.66.5.858","article-title":"Regulation of CD163 on human macrophages: cross-linking of CD163 induces signaling and activation","volume":"66","author":"Van den Heuvel","year":"1999","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.arteri.2024.04.002_bib0265","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jlb.67.1.97","article-title":"Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli","volume":"67","author":"Buechler","year":"2000","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.arteri.2024.04.002_bib0270","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/CIRCRESAHA.109.199505","article-title":"CXCL4 downregulates the atheroprotective hemoglobin receptor CD163 in human macrophages","volume":"106","author":"Gleissner","year":"2010","journal-title":"Cir Res"},{"key":"10.1016\/j.arteri.2024.04.002_bib0275","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1021\/pr101230y","article-title":"Extracellular hemoglobin polarizes the macrophage proteome toward Hb-clearance, enhanced antioxidant capacity and suppressed HLA class 2 expression","volume":"10","author":"Kaempfer","year":"2011","journal-title":"J Proteome Res"},{"key":"10.1016\/j.arteri.2024.04.002_bib0280","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.atherosclerosis.2005.05.004","article-title":"The monocytic lineage specific soluble CD163 is a plasma marker of coronary atherosclerosis","volume":"184","author":"Aristoteli","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.arteri.2024.04.002_bib0285","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1161\/ATVBAHA.110.203364","article-title":"Peripheral artery disease is associated with a high CD163\/TWEAK plasma ratio","volume":"30","author":"Moreno","year":"2010","journal-title":"Arterioscler Thromb Vas Biol"},{"key":"10.1016\/j.arteri.2024.04.002_bib0290","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/eurheartj\/ehr123","article-title":"In vitro and in vivo evidence for the role of elastase shedding of CD163 in human atherothrombosis","volume":"33","author":"Moreno","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.arteri.2024.04.002_bib0295","doi-asserted-by":"crossref","first-page":"740420","DOI":"10.3389\/fneur.2021.740420","article-title":"Circulating soluble CD163: a potential predictor for the functional outcome of acute ischemic stroke","volume":"12","author":"Sun","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.arteri.2024.04.002_bib0300","doi-asserted-by":"crossref","first-page":"e024374","DOI":"10.1161\/JAHA.121.024374","article-title":"Circulating soluble CD163, association with cardiovascular outcomes and mortality, and identification of genetic variants in older individuals: the cardiovascular health study","volume":"11","author":"Durda","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.arteri.2024.04.002_bib0305","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/rheumatology\/keaa374","article-title":"Cardiovascular risk and mortality in rheumatoid arthritis compared with diabetes mellitus and the general population","volume":"60","author":"L\u00f8gstrup","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.arteri.2024.04.002_bib0310","doi-asserted-by":"crossref","first-page":"102925","DOI":"10.1016\/j.autrev.2021.102925","article-title":"Systematic review and meta-analysis of cardiovascular risk in rheumatological disease: symptomatic and non-symptomatic events in rheumatoid arthritis and systemic lupus erythematous","volume":"21","author":"Restivo","year":"2022","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.arteri.2024.04.002_bib0315","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1136\/annrheumdis-2011-200726","article-title":"Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"71","author":"Avina-Zubieta","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.arteri.2024.04.002_bib0320","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.autrev.2016.07.026","article-title":"Cardiovascular risk assessment in patients with rheumatoid arthritis: the relevance of clinical, genetic and serological markers","volume":"15","author":"L\u00f3pez-Mej\u00edas","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.arteri.2024.04.002_bib0325","doi-asserted-by":"crossref","first-page":"820263","DOI":"10.3389\/fmed.2022.820263","article-title":"Novel surrogate markers of cardiovascular risk the setting of autoimmune rheumatic diseases: current data and implications for the future","volume":"9","author":"Mandel","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.arteri.2024.04.002_bib0330","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/annrheumdis-2017-211649","article-title":"Monocyte alterations in rheumatoid arthritis are dominated by preterm release from bone marrow and prominent triggering in the joint","volume":"77","author":"Smiljanovic","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.arteri.2024.04.002_bib0335","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1046\/j.1365-2249.2002.01963.x","article-title":"Elevated levels of soluble CD163 in sera and fluids from rheumatoid arthritis patients and inhibition of the shedding of CD163 by TIMP-3","volume":"130","author":"Matsushita","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.arteri.2024.04.002_bib0340","first-page":"689","article-title":"Soluble macrophage-derived CD163 is a marker of disease activity and progression in early rheumatoid arthritis","volume":"29","author":"Greisen","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.arteri.2024.04.002_bib0345","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00296-012-2459-4","article-title":"Soluble CD163 serum levels are elevated and correlated with IL-12 and CXCL10 in patients with long-standing rheumatoid arthritis","volume":"33","author":"Jude","year":"2013","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.arteri.2024.04.002_bib0350","first-page":"498","article-title":"Macrophage activity assessed by soluble CD163 in early rheumatoid arthritis: association with disease activity but different response patterns to synthetic and biologic DMARDs","volume":"33","author":"Greisen","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.arteri.2024.04.002_bib0355","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s13075-022-02946-z","article-title":"The biological activity of serum bacterial lipopolysaccharides associates with disease activity and likelihood of achieving remission in patients with rheumatoid arthritis","volume":"24","author":"Parantainen","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.arteri.2024.04.002_bib0360","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/annrheumdis-2021-eular.2990","article-title":"POS1001 Clinical and surrogate cardiovascular risk assessment and its relationship with psoriatic arthritis pathogenesis","volume":"80","author":"Barbarroja Puerto","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.arteri.2024.04.002_bib0365","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cyto.2018.05.017","article-title":"Soluble CD163, a unique biomarker to evaluate the disease activity, exhibits macrophage activation in systemic juvenile idiopathic arthritis","volume":"110","author":"Sakumura","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.arteri.2024.04.002_bib0370","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/03009742.2019.1614213","article-title":"Soluble CD163 is a biomarker for accelerated atherosclerosis in systemic lupus erythematosus patients at apparent low risk for cardiovascular disease","volume":"49","author":"David","year":"2020","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.arteri.2024.04.002_bib0375","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/joim.13490","article-title":"Soluble CD163 and incident cardiovascular events in patients with systemic lupus erythematosus: an observational cohort study","volume":"292","author":"David","year":"2022","journal-title":"J Intern Med"},{"key":"10.1016\/j.arteri.2024.04.002_bib0380","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.arteri.2024.04.002_bib0385","unstructured":"Organization, World Health. Obesity: preventing and managing the global epidemic: World Health Organization; 2000."},{"key":"10.1016\/j.arteri.2024.04.002_bib0390","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.arteri.2024.04.002_bib0395","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00132577-200512000-00018","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute scientific statement: executive summary","volume":"4","author":"Grundy","year":"2005","journal-title":"Crit Pathw Cardiol"},{"key":"10.1016\/j.arteri.2024.04.002_bib0400","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s10067-020-05218-w","article-title":"PON-1 haplotype (\u2212108C>T, L55M, and Q192R) modulates the serum levels and activity PONase promoting an atherogenic lipid profile in rheumatoid arthritis patients","volume":"40","author":"Zaragoza-Garc\u00eda","year":"2021","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.arteri.2024.04.002_bib0405","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0009-9120(01)00263-6","article-title":"The plasma parameter log (TG\/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL))","volume":"34","author":"Dobi\u00e1sov\u00e1","year":"2001","journal-title":"Clin Biochem"},{"key":"10.1016\/j.arteri.2024.04.002_bib0410","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1038\/oby.2009.453","article-title":"The lipid accumulation product and all-cause mortality in patients at high cardiovascular risk: a PreCIS database study","volume":"18","author":"Ioachimescu","year":"2010","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.arteri.2024.04.002_bib0415","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cca.2014.08.042","article-title":"The \u201ccardiometabolic index\u201d as a new marker determined by adiposity and blood lipids for discrimination of diabetes mellitus","volume":"438","author":"Wakabayashi","year":"2015","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.arteri.2024.04.002_bib0420","doi-asserted-by":"crossref","first-page":"j2099","DOI":"10.1136\/bmj.j2099","article-title":"Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study","volume":"357","author":"Hippisley-Cox","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.arteri.2024.04.002_bib0425","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/art.39006","article-title":"Soluble macrophage biomarkers indicate inflammatory phenotypes in patients with knee osteoarthritis","volume":"67","author":"Daghestani","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.arteri.2024.04.002_bib0430","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1365-2362.2012.02714.x","article-title":"Soluble CD163 is associated with body mass index and blood pressure in hypertensive obese Saudi patients","volume":"42","author":"Al-Daghri","year":"2012","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.arteri.2024.04.002_bib0435","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2265.2011.04284.x","article-title":"Relationship between monocyte\/macrophage activation marker soluble CD163 and insulin resistance in obese and normal-weight subjects","volume":"77","author":"Zanni","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.arteri.2024.04.002_bib0440","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1189\/jlb.0410235","article-title":"Tumor necrosis factor \u03b1-converting enzyme (TACE\/ADAM17) mediates ectodomain shedding of the scavenger receptor CD163","volume":"88","author":"Etzerodt","year":"2010","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.arteri.2024.04.002_bib0445","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1365-2249.2000.01281.x","article-title":"Ageing, tumour necrosis factor-alpha (TNF-alpha) and atherosclerosis","volume":"121","author":"Bruunsgaard","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.arteri.2024.04.002_bib0450","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12291-016-0566-9","article-title":"Serum lipid alterations in early rheumatoid arthritis patients on disease modifying anti rheumatoid therapy","volume":"32","author":"Parveen","year":"2017","journal-title":"Indian J Clin Biochem"},{"key":"10.1016\/j.arteri.2024.04.002_bib0455","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/art.39502","article-title":"Association of triple therapy with improvement in cholesterol profiles over two years follow-up in the Treatment of Early Aggressive Rheumatoid Trial","volume":"68","author":"Charles-Schoeman","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.arteri.2024.04.002_bib0460","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/s41591-020-0939-8","article-title":"Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis","volume":"26","author":"Alivernini","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.arteri.2024.04.002_bib0465","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1373\/clinchem.2010.154724","article-title":"Serum soluble CD163 predicts risk of type 2 diabetes in the general population","volume":"57","author":"M\u00f8ller","year":"2011","journal-title":"Clin Chem"},{"key":"10.1016\/j.arteri.2024.04.002_bib0470","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1007\/s00125-012-2533-1","article-title":"Soluble CD163: a biomarker linking macrophages and insulin resistance","volume":"55","author":"Parkner","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.arteri.2024.04.002_bib0475","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/oby.20376","article-title":"The macrophage-specific serum marker, soluble CD163, is increased in obesity and reduced after dietary-induced weight loss","volume":"21","author":"Fjeldborg","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.arteri.2024.04.002_bib0480","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3390\/nu11040940","article-title":"Soluble CD163-associated dietary patterns and the risk of metabolic syndrome","volume":"11","author":"Hu","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.arteri.2024.04.002_bib0485","first-page":"266","article-title":"Rheumatoid arthritis, statin indication and lipid goals: analysis according to different recommendations","volume":"18","author":"Masson","year":"2022","journal-title":"Rheumatol Clin (Engl Ed)"},{"key":"10.1016\/j.arteri.2024.04.002_bib0490","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1093\/rheumatology\/keaa718","article-title":"Combined use of QRISK3 and SCORE as predictors of carotid plaques in patients with rheumatoid arthritis","volume":"60","author":"Corrales","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.arteri.2024.04.002_bib0495","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/00365513.2017.1331462","article-title":"Soluble CD206 plasma levels in rheumatoid arthritis reflect decreased in disease activity","volume":"77","author":"Heftdal","year":"2017","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.arteri.2024.04.002_bib0500","doi-asserted-by":"crossref","first-page":"1253913","DOI":"10.3389\/fimmu.2023.1253913","article-title":"A serum metabolic biomarker panel for early rheumatoid arthritis","volume":"14","author":"Rodr\u00edguez-Muguruza","year":"2023","journal-title":"Front Immunol"}],"container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916824000391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916824000391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T08:38:34Z","timestamp":1746088714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0214916824000391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0214916824000391"],"URL":"https:\/\/doi.org\/10.1016\/j.arteri.2024.04.002","relation":{},"ISSN":["0214-9168"],"issn-type":[{"type":"print","value":"0214-9168"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levels of sCD163 in women rheumatoid arthritis: Relationship with cardiovascular risk markers","name":"articletitle","label":"Article Title"},{"value":"Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arteri.2024.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Sociedad Espa\u00f1ola de Arteriosclerosis. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100721"}}